Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,244
Total Claims
$1.9M
Drug Cost
473
Beneficiaries
$4,096
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+190%
Cost per patient vs peers
$4,096 vs $1,411 avg
+64%
Brand preference vs peers
17.5% vs 10.6% avg
Brand vs Generic
Brand: 1,736 claims · $1.6M
Generic: 8,201 claims · $305K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 131 | $165K |
| Apixaban | 107 | $130K |
| Linaclotide | 142 | $117K |
| Dulaglutide | 87 | $116K |
| Naproxen/Esomeprazole Mag | 64 | $114K |
| Semaglutide | 85 | $99K |
| Sitagliptin Phosphate | 53 | $73K |
| Dapagliflozin Propanediol | 61 | $73K |
| Sacubitril/Valsartan | 35 | $51K |
| Lipase/Protease/Amylase | 13 | $42K |
| Diclofenac Sodium | 109 | $38K |
| Omeprazole/Sodium Bicarbonate | 22 | $35K |
| Emtricitabine/Tenofov Alafenam | 13 | $30K |
| Dolutegravir Sodium | 13 | $30K |
| Semaglutide | 19 | $30K |
Prescribing Profile
Patient Profile
72
Avg Age
60%
Female
1.22
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data